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Abstract
 
Wiskott-Aldrich syndrome protein–interacting protein (WIP) stabilizes actin filaments and is
important for immunoreceptor-mediated signal transduction leading to actin cytoskeleton rear-
rangement in T and B cells. Here we report a role for WIP in signaling pathways downstream
of the high affinity receptor for immunoglobulin (Ig)E (Fc
 

 
RI) in mast cells. WIP-deficient
bone marrow–derived mast cells (BMMCs) were impaired in their capacity to degranulate and
secrete interleukin 6 after Fc
 

 
RI ligation. Calcium mobilization, phosphorylation of Syk, phos-
pholipase C-g2, and c-Jun NH
 
2
 
-terminal kinase were markedly decreased in WIP-deficient
BMMCs. WIP was found to associate with Syk after Fc
 

 
RI ligation and to inhibit Syk degradation
as evidenced by markedly diminished Syk levels in WIP-deficient BMMCs. WIP-deficient
BMMCs exhibited no apparent defect in their subcortical actin network and were normal in
their ability to form protrusions when exposed to an IgE-coated surface. However, the kinetics
of actin changes and the cell shape changes that follow Fc
 

 
RI signaling were altered in WIP-
deficient BMMCs. These results suggest that WIP regulates Fc
 

 
RI-mediated mast cell activation
by regulating Syk levels and actin cytoskeleton rearrangement.
Key words: signal transduction • WIP • WASP • Wiskott-Aldrich syndrome • cytoskeleton
 
Introduction
 
Wiskott-Aldrich syndrome (WAS), an X-linked immuno-
deficiency, is caused by mutations in the gene encoding the
WAS protein (WASP; 1). Hematopoietic cells from WAS
patients show abnormalities in response to surface receptor–
induced activation and in cytoskeletal function (2–6). These
studies, together with the results from WASP-deficient
mice, indicate that WASP functions as a scaffold or adaptor
protein that regulates actin cytoskeleton reorganization and
transcriptional activity (7, 8). The WASP-interacting protein
(WIP) binds to the NH
 
2
 
-terminal WH1 domain of WASP
within a region that is frequently mutated in patients with
WAS (9, 10). Point mutations within this region abrogate
the binding of WASP to WIP (11). Interaction of WIP with
WASP has been demonstrated to be involved in the regula-
tion of T cell activation (12). T cells from WIP-deficient
mice are impaired in their ability to proliferate and secrete
IL-2 in response to TCR stimulation and have an abnormal
subcortical actin filament network (13). These results support
an important role for WIP in regulating the activation-
induced rearrangement of the actin cytoskeleton down-
stream of immunoreceptor stimulation. Both WIP and
WASP are also expressed in mast cells. These cells bear on
their surface the high affinity receptor for IgE (Fc
 

 
RI), a
member of the multichain immune recognition receptors
(14). Upon Fc
 

 
RI aggregation, immunoreceptor tyrosine-
based activation motifs of the g and b subunits become
phosphorylated by the Src family tyrosine kinase lyn and
recruit the protein tyrosine kinase Syk, which in turn phos-
phorylates intracellular proteins such as LAT, phospholipase
C (PLC)-
 

 
, Vav, and the adaptor protein SLP-76 (15–18).
Mast cells undergo dramatic morphological changes
upon IgE-dependent stimulation, which triggers the release
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of vasoactive agents from preformed granules as well as the
synthesis and release of lipid mediators and cytokines.
Fc
 

 
RI has been shown to interact directly with the actin
cytoskeleton and rearrangement of the actin cytoskeleton is
associated with degranulation (19–21). Cytochalasin D, an
inhibitor for actin polymerization, has been shown to en-
hance granule exocytosis upon Fc
 

 
RI ligation (21, 22).
We have used mast cells derived from WIP-deficient
mice to examine the role of WIP in Fc
 

 
RI signaling. We
found that degranulation, IL-6 production, and actin cyto-
skeleton dynamics after Fc
 

 
RI ligation were impaired in
WIP
 

 
/
 
 
 
mast cells. WIP was found to associate with Syk
after Fc
 

 
RI ligation and to inhibit Syk degradation as evi-
denced by markedly diminished Syk levels in WIP-defi-
cient bone marrow–derived mast cells (BMMCs). These
results suggest that WIP regulates Fc
 

 
RI-mediated mast
cell activation by regulating Syk levels and actin cytoskele-
ton rearrangement.
 
Materials and Methods
 
Cells and Cell Culture.
 
The generation of WIP-deficient mice
has been described elsewhere (13). Bone marrow cells were ob-
tained by flushing the femur and tibia bones of WIP
 

 
/
 
 
 
mice and
from WT littermates and were cultured in WEHI-3–conditioned
medium (WCM) as a source of IL-3 (23). After 3–5 wk of cul-
ture, 
 

 
90% of the cells derived from the bone marrow of WIP
 

 
/
 

 
and WT mice were mast cells, as assessed for IgE binding by
FACS
 
® 
 
analysis. BMMCs were incubated with mouse IgE, bio-
tinylated rat anti–mouse IgE, and streptavidin-CyChrome (all from
BD Biosciences). Cells were analyzed on a FACSCalibur™ flow
cytometer (Becton Dickinson).
 
Enumeration of Mast Cells in Ear Skin.
 
Ears from WIP
 

 
/
 

 
(
 
n 
 
 
 
2) and control mice (
 
n 
 
 
 
2) were fixed in 2% paraformalde-
hyde and processed into 3-mm–thick, paraffin-embedded sec-
tions stained with toluidine blue. Slides were examined by light
microscopy for determination of mast cell numbers. Mast cells in
six randomly chosen fields were counted per slide (six slides total
for both WIP
 

 
/
 
 
 
and control mice).
 
Blood Histamine Measurements.
 
Mice were sensitized with 3
mg mouse IgE anti-DNP mAb SPE-7 (Sigma-Aldrich) by i.v. in-
jection in the retro-orbital vein. 24 h later, the mice were chal-
lenged with i.v. injection of human serum albumin (HSA)-DNP
(0.5 mg per mouse). Blood histamine levels were determined by
competitive RIA (Immunotech) on 100 ml plasma 1.5 min after
antigen challenge according to the manufacturer’s instructions.
 

 
-Hexosaminidase Release Assay.
 
10
 
6 
 
BMMCs were incu-
bated in WCM containing 2.5 mg/ml rat IgE for 1 h on ice. Af-
ter washing, pellets were resuspended on ice in WCM contain-
ing 0.1, 1, and 10 mg/ml F(ab
 

 
)
 
2 
 
fragments of mouse anti–rat Igs
(Jackson ImmunoResearch Laboratories) or 10 mM ionomycin
and incubated at 37
 
	
 
C for 20 min. The reaction was stopped by
centrifugation. The pellets were resuspended in their original
volume and lysed with WCM containing 0.5% Triton X-100.
Aliquots of supernatants and cell lysates were incubated in du-
plicates with substrate solution (1.3 mg/ml 
 
p
 
-nitrophenyl-b-
 
d
 
-2-acetamido-2-deoxyglucopyranozide in 0.1 M citrate, pH
4.5). The percent release values for each experimental condi-
tion were calculated by the formula [S/(S
 


 
P)] 
 
 
 
100, where
S and P are the b-hexosaminidase contents of the supernatant
(S) and pellet (P) from each sample. The net release values
were obtained by subtracting the OD for medium alone from
S and P.
 
Measurement of Intracellular Calcium.
 
10 
 
 
 
10
 
6
 
/ml BMMCs
were preloaded for 1 h on ice with 5 or 10 mg/ml rat IgE and 1
mM of the calcium-sensitive dye indo 1-AM in calcium buffer
(PBS, pH 7.4, supplemented with 5 mM glucose, 1 mM CaCl
 
2
 
,
0.5 mM MgCl
 
2
 
, 1 mg/ml BSA, 10 mM Hepes). Cells were
washed twice with calcium buffer and resuspended to the original
concentration. 300 ml of cells were analyzed for calcium mobiliza-
tion in a spectrophotometer (LS50; PerkinElmer). Excitation
wavelength was 354 nm and emission wavelengths were 405 and
485 nm. Receptor-mediated change in calcium concentration was
monitored after the addition of 25 or 50 mg/ml F(ab
 

 
)
 
2 
 
anti–rat Ig.
Values were plotted as ratio of fluorescence at 405 and 485 nm.
 
Measurement of IL-6 Production.
 
10
 
6 
 
BMMCs preloaded for
1 h on ice with 2.5 mg/ml rat IgE were incubated with 1 mg/ml
of F(ab
 

 
)
 
2 
 
anti–rat Ig for 24 h in WCM at 37
 
	
 
C. Supernatants
were assayed for IL-6 using an ELISA kit (R&D Systems).
 
Western Blotting and Immunoprecipitation.
 
WIP, Syk, and actin
protein expression was examined by Western blotting using rab-
bit anti–WIP (9, 24), rabbit anti–Syk (Santa Cruz Biotechnology,
Inc.), and actin mAb (Chemicon).
For immunoprecipitation experiments, BMMCs were pre-
loaded for 1 h on ice with 2.5 mg/ml rat IgE, and then stimulated
for 7 min at 37
 
	
 
C with 10 mg/ml F(ab
 

 
)
 
2
 
 anti–rat Ig in WCM.
After centrifugation, cells were lysed for 15 min on ice in lysis
buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1%
NP-40 supplemented with the following protease inhibitors: 3
mM diisopropyl fluorophosphate [Sigma-Aldrich], 1 mM PMSF
[Sigma-Aldrich], 50 mg/ml antipain, and Complete™ protease
inhibitor cocktail [all from Roche Molecular Biochemicals] and
the following phosphatase inhibitors: 0.5 mM Na
 
3
 
VO
 
4 
 
and 5 mM
NaF). Clarified cell lysates were subjected to immunoprecipita-
tion with antibody to Syk, PLC-
 

 
2 (Santa Cruz Biotechnology,
Inc.), or SLP-76 (25), and then probed with antiphosphotyrosine
mAb PT-66 or 4G-10 (Sigma-Aldrich). WIP immunoprecipitates
were probed with anti-Syk antibody. In some experiments, cells
were incubated with calpeptin (Calbiochem), MG132 (Sigma-
Aldrich), or both for 4 h before analysis.
Activated mitogen-activated protein (MAP) kinases were de-
tected by immunoblotting cell lysates with phospho-protein–spe-
cific antibodies (phospho-ERK1/2; Santa Cruz Biotechnology,
Inc.), phospho-SAPK/JNK, and phospho-p38 (both from New
England Biolabs, Inc.). Immunoreactive bands were detected by
enhanced chemiluminescence (Amersham Biosciences).
 
Northern Blot Analysis of Syk mRNA.
 
Total RNA from
BMMCs was prepared using Trizol reagent (Sigma-Aldrich).
Northern blot analysis for Syk was performed using Northern-
Max Kit (Ambion) and a rat Syk cDNA, provided by R. Siraga-
nian (National Institutes of Health, Bethesda, MD).
 
Spreading on IgE-coated Glass Coverslips.
 
Glass coverslips were
coated with mouse monoclonal IgE anti-ovalbumin (provided by
M. Kiniwa, Taiho Pharmaceutical Co. Ltd., Saitama, Japan) over-
night at 4
 
	
 
C. 0.2 
 
 
 
10
 
6
 
/ml BMMCs were allowed to attach to the
glass for 15, 30, and 60 min at 37
 
	
 
C. Unattached cells were washed
off and cells were fixed with 2% formaldehyde and then counted
to determine the fraction of adherent cells. When indicated,
BMMCs were preincubated with cytochalasin D at 10 mM for 1 h
on ice, washed twice, and resuspended in culture medium. BMMCs
were counted under a Nikon Eclipse TE2000 microscope.
To determine the percentage of attached cells, BMMCs (0.3 
 

 
10
 
6
 
/well in WCM) were allowed to attach to IgE-coated glass
coverslips in 24-well plates for 1 h at 37
 
	
 
C in quadruplicates. The
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plate was then agitated to dislocate nonadherent cells and the su-
pernatant was collected and cells were sedimented by centrifuga-
tion. The pellet as well as the adherent cells were then lysed in
the same volume of PBS 0.1% Triton X-100. 
 

 
-hexosaminidase
content was determined as described above. Percent adherence
was calculated by the formula [A/(A
 


 
S)] 
 
 
 
100, where A and S
are the 
 

 
-hexosaminidase contents of the adherent cells (A) and
cells in supernatant (S) from each sample.
 
Electron Microscopy.
 
0.2 
 
 
 
10
 
6
 
/ml BMMCs were allowed to
attach to IgE-coated coverslips for 60 min at 37
 
	
 
C. Cytoskele-
tons of attached cells were prepared by extraction with 0.75%
Triton X-100 in PHEM buffer containing protease inhibitors
and 2 mM phalloidin as previously described (26). Extracted
BMMCs were briefly washed in PHEM buffer (60 mM Pipes, 25
mM Hepes, 10 mM EGTA, and 2 mM MgCl
 
2
 
, pH 6.9) and
fixed with 1% glutaraldehyde in PHEM buffer for 10 min. Cyto-
skeletons were washed trice with double distilled water just be-
fore freezing. Samples were rapid frozen, freeze dried, and rotary
shadowed with 1.2 nm tantalum-tungsten followed by 2.5 nm
carbon. Specimens were examined and photographed in a JEOL
1200-EX electron microscope using an accelerating voltage of
100 kV.
 
Determination of Cellular F-Actin.
 
10
 
6 
 
BMMCs preloaded for
1 h on ice with 2.5 mg/ml rat IgE were incubated with 10 mg/ml
F(ab
 

 
)
 
2 
 
anti–rat Ig for the indicated time in WCM at 37
 
	
 
C. Cells
were immediately fixed for 10 min by adding 4% formaldehyde
(2% final concentration). They were then permeabilized and
stained in a single step with 0.1% Triton X-100 and 1 mg/ml
phalloidin-TRITC in PHEM buffer for 40 min and analyzed by
FACS
 
®
 
.
 
Measurement of Filament Ends.
 
10 
 
 
 
10
 
6
 
/ml BMMCs were
preloaded for 1 h on ice with 2.5 mg/ml rat IgE in calcium
buffer. Cells were washed twice in calcium buffer and resus-
pended at the concentration of 20 
 
 
 
10
 
6
 
/ml. Cells (10
 
6
 
/ml in 50
 

 
l) were activated by the addition of an equal volume of 20 mg/
ml F(ab
 

 
)
 
2 
 
anti–rat IgE for 1, 2, 5, and 15 min. Resting and acti-
vated cells were extracted with 0.1% Triton in PHEM buffer
containing protease inhibitors and 1 mM phallacidin. 185 ml of
100 mM KCl, 2 mM MgCl
 
2
 
, 0.5 mM ATP, 0.1 mM EGTA, 0.5
mM DTT, and 10 mM Tris, pH 7.0, was then added and the po-
lymerization rate assay was started by the addition of 15 ml
monomeric pyrene-labeled rabbit skeletal muscle actin to a final
concentration of 1 mM. Pyrene-actin fluorescence was recorded
using a spectrofluorimeter (LS50; PerkinElmer). Excitation and
emission wavelengths were 366 and 386 nm, respectively. Activ-
ity inhibited by 2 mM cytochalasin B is defined as barbed end ac-
tin assembly. Activity not inhibited by cytochalasin B is defined as
pointed end actin assembly. The number of actin filament ends
was determined as previously described (27). Initial barbed and
pointed end addition rates in 1 mM actin solution are 10 and 1
monomers s
 

 
1
 
, respectively.
 
Time Lapse Video Microscopy.
 
For degranulation on fibronec-
tin, cells were preloaded with 2.5 mg/ml IgE and transferred at
0.2 
 
 
 
10
 
6
 
/ml into 24-well plates that contained glass coverslips
that were coated with fibronectin at 10 mg/ml. Cells were al-
lowed to sediment at room temperature for 10 min and then
were transferred to 37
 
	
 
C for 20 min. Coverslips with adherent
cells were briefly dipped in prewarmed WCM and then trans-
ferred to the warm stage of the Nikon Eclipse TE2000 micro-
scope. Images were acquired with a CCD-300-RC charge-cou-
pled device (Dage-MTI) at 
 

 
400. Frames were taken every 6 s
for 15 min. After 1 min of recording, 1 mg/ml F(ab
 

 
)
 
2 
 
fragments
of mouse anti–rat Ig was added.
 
Statistical Analysis and Densitometry.
 
Statistical analyses of the
data were performed with Prism software (version 3.0a). Blots
were scanned and analyzed with NIH Image software (version
1.62). Results were expressed as fold induction over baseline and
were normalized to signal for loading.
 
Results
 
BMMCs Develop Normally in the Absence of WIP.
 
Mouse bone marrow cells cultured in the presence of IL-3
differentiate into mast cells (23). After 4 wk of culture in
IL-3–containing WCM, a similar number and percentage
of cells (90%) from WIP/ and WT mice differentiated
to mast cells as evidenced by their capacity to bind IgE
(Fig. 1 A). Furthermore, the same proportion of cells con-
tained metachromatic granules when stained with toluidine
blue (not depicted).
Lysates from WT and WIP-deficient cells were exam-
ined by Western blotting for expression of WIP. As shown
in Fig. 1 B, only WT cells express WIP. The kinetics of
cell growth and differentiation of WIP/ and WT
BMMCs were similar (not depicted). We also examined
the number of tissue mast cells in WIP/ mice. The num-
ber of mast cells in the ear skin of WIP/ mice (16  4
per high power field, n  6) was comparable to that of
controls (16  3 per high power field, n  6).
IgE-mediated Systemic Histamine Release Is Greatly Dimin-
ished in WIP Mice. Adoptive transfer of IgE antibodies
to normal mice primes them to undergo passive systemic
anaphylactic reactions in response to intravenous challenge
with specific antigen. IgE-mediated anaphylaxis is depen-
dent both on mast cells and FcRI signaling as it is dimin-
Figure 1. Characterization of in vitro–derived WIP BMMCs. (A) IgE
receptor expression on BMMCs form WT and WIP/. Cells were
treated with mouse IgE and then incubated with biotinylated anti-IgE
and streptavidin-CyChrome (bold line). Control staining was with biotiny-
lated anti-IgE and streptavidin-CyChrome alone (thin line). (B) WIP
protein expression was assessed by immunoblotting after separation of
proteins by SDS-PAGE.
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ished in mast cell–deficient W/Wv mice (28, 29), virtually
absent in mast cell–deficient Sl/Sld mice (30), and dramati-
cally reduced in FcRI-deficient mice (31). Dramatic in-
crease of plasma concentration of histamine, a major vasoac-
tive mediator released by activated mast cells and basophils,
has been shown to correlate with systemic anaphylaxis (32).
To evaluate whether expression of WIP is important in reg-
ulating IgE-dependent systemic release of histamine, we pas-
sively sensitized four WIP/ mice and six control litter-
mates with mouse IgE anti-DNP mAb. 24 h later, mice
were challenged with DNP-HSA and plasma histamine
concentration was determined before and 1.5 min after chal-
lenge with antigen (Fig. 2 A). Plasma histamine levels before
antigen administration were comparable in WT and WIP/
mice. After antigen challenge, the increase in plasma hista-
mine concentration was dramatic in WT mice but minimal
in WIP/ mice (Fig. 2 A). This finding suggests that WIP is
essential for IgE-mediated systemic anaphylaxis in mice.
IgE-dependent Release of -Hexosaminidase of WIP-deficient
Mast Cells. Next, we tested the capacity of mast cells de-
rived from WIP/ mice to release preformed mediators
stored in their granules upon cross-linking of FcRI-bound
IgE by antigen in vitro. BMMCs derived from WT and
WIP/ mice were sensitized with rat IgE. FcRI-bound
IgE was cross-linked 1 h later with increasing concentra-
tions of F(ab)2 anti–rat Ig and the release of the granular en-
zyme -hexosaminidase was determined after 20 min of in-
cubation. FcRI-mediated release of -hexosaminidase by
WIP/ BMMCs was significantly reduced at all concentra-
tions of cross-linker used as compared with WT cells (Fig. 2
B). Furthermore, -hexosaminidase release in WIP/
BMMCs was suppressed to the same extent after 1, 2, 5, 10,
15, and 20 min at a single dose of cross-linking antibody
(1 mg/ml) tested (not depicted). -Hexosaminidase release
was complete at 5 min and did not increase significantly
thereafter for both cell types. Granule exocytosis induced by
Figure 2. In vivo IgE-dependent histamine release and
in vitro degranulation is diminished in WIP mice. (A)
WIP/ mice and WT controls were sensitized with 3 mg
IgE by i.v. injection in the retro-orbital vein. 24 h later the
mice were challenged with i.v. injection of HSA-DNP.
Blood histamine levels were determined by competitive
RIA in plasma collected 1.5 min after antigen challenge. (B)
IgE-mediated in vitro degranulation of WIP/ BMMCs.
Release of -hexosaminidase. BMMCs preloaded with
IgE were stimulated with F(ab)2 anti–rat Ig at indicated
concentrations. Results represent mean  SD of three
experiments from two independently derived WT and
WIP/ cell lines, each analyzed in duplicates. Statistical anal-
ysis was performed using the Student’s t test.
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ionomycin was comparable in WT and WIP/ cells, indi-
cating that ionophore-induced granule secretion is normal
in WIP/ BMMCs (not depicted).
FcRI-mediated IL-6 Production Is Impaired in WIP-deficient
BMMCs. To assess the role of WIP in FcRI-mediated
cytokine production, IL-6 concentration was measured in
cell culture supernatants of BMMCs 24 h after stimulation.
WIP/ BMMCs secreted markedly less IL-6 than WT
controls at all concentrations of cross-linker used (Fig. 3).
Intracellular Calcium Concentration and Tyrosine Phosphory-
lation of PLC-2 after Cross-linking of FcRI. Upon FcRI
cross-linking, PLC- becomes rapidly phosphorylated and
activated to hydrolyze membrane phosphoinositides to
generate IP3, which initiates an increase in intracellular cal-
cium. A rapid sustained increase in intracellular calcium
levels is important for FcRI-mediated degranulation and
cytokine release in mast cells (33, 34). After FcRI ligation,
intracellular calcium levels in WIP/ BMMCs rapidly in-
creased but remained significantly below those observed in
WT BMMCs throughout the 6-min observation period
(Fig. 4 A). Similarly decreased calcium fluxes were still ob-
served under conditions of higher FcRI cross-linking (10
mg/ml rat IgE and 50 mg F(ab)2 anti–rat Ig).
Although BMMCs express both PLC- isoforms, it has
been demonstrated that PLC-2 is crucial for mast cell de-
granulation and IL-6 secretion (35). Tyrosine phosphoryla-
tion of PLC-2 was markedly reduced in WIP/ BMMCs
after FcRI ligation as compared with WT controls (Fig. 4
B). The decrease of PLC-2 tyrosine phosphorylation is
not a consequence of a general failure to phosphorylate in-
tracellular substrates as the pattern and intensity of global
phosphorylation was the same in WT and WIP/
BMMCs (not depicted). Moreover, SLP-76 that becomes
rapidly tyrosine phosphorylated by Syk after FcRI ligation
was normally phosphorylated (Fig. 4 C).
MAP Kinase Activation in Response to FcRI Ligation.
FcRI cross-linking induces phosphorylation and activa-
tion of the MAP kinases Erk, JNK, and p38 in mast cells
(15, 36). The phosphorylation status of the MAP kinases
Erk, JNK, and p38 in WIP/ BMMCs after FcRI cross-
linking was examined by Western blotting with antibodies
that recognize selectively these kinases in their phosphory-
lated state. Phosphorylation of Erk and p38 was minimally
affected in WIP/ mast cells compared with WT controls
(Fig. 5, A and B). In contrast, FcRI-mediated phosphory-
lation of JNK, both p54 and p46 forms, was reduced and
less sustained in WIP/ mast cells (Fig. 5 C).
Figure 3. IgE-mediated IL-6 release of WIP BMMCs. IL-6 release
by BMMCs. BMMCs preloaded with IgE were incubated with F(ab)2
anti–rat Ig for 24 h. IL-6 release was determined by ELISA. Results represent
mean  SD of three experiments. Statistical analysis was performed using
the Student’s t test.
Figure 4. Calcium mobilization and tyrosine phosphorylation of PLC-
2 in response to FcRI ligation. (A) Change of fluorescence of the calcium-
sensitive dye indo 1-AM was monitored for the indicated time. IgE-sensitized
cells were stimulated with F(ab)2 anti–rat Ig at the indicated time points.
Values were plotted as ratio of fluorescence at 405 and 485 nm. (B) Tyrosine
phosphorylation of PLC-2 in WIP/ BMMCs. IgE-sensitized BMMCs
were activated by FcRI cross-linking with F(ab)2 anti–rat Ig for the
indicated time at 37	C. Cell lysates were immunoprecipitated with anti–
PLC-2. PLC-2 tyrosine phosphorylation was analyzed by immunoblotting
with antiphosphotyrosine antibody. The membrane was reprobed with
anti–PLC-2 to control for loading. (C) Tyrosine phosphorylation of
SLP-76. Cells were stimulated as for PLC-2 tyrosine phosphorylation
and cell lysates were immunoprecipitated with anti–SLP-76 antibody.
The membrane was reprobed with anti–SLP-76 to control for loading.
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WIP Associates with Syk after FcRI Ligation and Stabilizes
Syk Protein. Syk plays a critical role in transmitting signals
from FcRI. The multiple defects in FcRI signaling in
WIP/ BMMCs prompted us to examine whether WIP is
linked to Syk. Phosphorylated Syk is known to associate
with the SH2 and SH3 domains containing adaptor protein
CrkL via phosphotyrosine–SH2 domain interactions (37).
We have recently shown that CrkL directly binds to WIP
and that the Syk homologue ZAP-70 associates with WIP
after TCR ligation, suggesting that CrkL bridges phos-
phorylated ZAP-70 to WIP (37). Therefore, we examined
whether Syk and WIP associate after FcRI ligation. WIP
immunoprecipitates from lysates of BMMCs from WT
mice were probed for Syk before and after FcRI ligation.
There was no detectable Syk in WIP immunoprecipitates
from unstimulated cells. FcRI ligation resulted in the asso-
ciation of Syk with WIP (Fig. 6 A). These results suggest
that WIP and Syk are recruited to the same complex in ac-
tivated BMMCs.
Next, we examined tyrosine phosphorylation of Syk in
WIP/ BMMCs. Initial probing of BMMCs lysates for
Syk revealed a severe reduction in Syk protein levels in
WIP/ BMMCs (Fig. 6 B). This decrease was specific to
Syk because the levels of actin (Fig. 6 B), PLC-2, and
SLP-76 (Fig. 4, B and C) were unaffected. FcRI ligation
in WIP/ BMMCs resulted in the generation of decreased
amounts of phosphorylated Syk compared with WT BMMCs
(Fig. 6 C). Densitometry analysis revealed that this decrease
was commensurate with the decrease in Syk protein levels
as evidenced by comparable ratios of intensities of phos-
pho-Syk to total Syk bands after FcRI ligation in WIP/
BMMCs and WT controls. These results suggest that WIP
is essential for normal Syk protein expression.
The decrease in Syk protein expression was not due to
decreased Syk mRNA expression as Syk mRNA levels
were comparable in WIP/ and WT BMMCs as assessed
by Northern blot analysis (Fig. 6 D). Syk is subject to ubiq-
uitination by Cbl and subsequent degradation by the pro-
teasome in B cells and mast cells and is also a substrate for
calpain (38–40). We examined the effect of proteasome and
calpain inhibitors on Syk levels in WIP/ BMMCs. Pre-
treatment of WIP/ BMMCs for 6 h with the calpain in-
hibitor calpeptin and with the proteasome inhibitor MG132
resulted in an increase in Syk levels, which averaged 2.5 
0.6-fold in three experiments (Fig. 6 E). Neither inhibitor
alone had a detectable effect. Pretreatment with calpeptin
and MG132 caused no increase (1.1  0.3-fold) in Syk lev-
els in WT BMMCs. Taken together, these results suggest
that WIP inhibits the degradation of Syk in mast cells.
Spreading of Mast Cells on IgE-coated Slides. T cells spread
and extend protrusions when exposed to anti-TCR/CD3–
coated surfaces. This process involves actin cytoskeleton re-
organization, which is dependent on WASP and WIP (41,
42). Given the role of WIP in actin cytoskeleton organiza-
tion, we tested the ability of BMMCs from WT and WIP/
mice to attach and spread on IgE-coated glass coverslips.
WT mast cells did not attach to untreated glass slides (not
depicted) but adhered to IgE-coated coverslips. WIP/
mast cells adhered to IgE-coated coverslips equally as well as
WT BMMCs (Fig. 7 A). After attachment, a significant
proportion of WT BMMCs spread and extended mem-
brane protrusions (Fig. 7, B and C). Preincubation of WT
mast cells with the inhibitor of actin polymerization, cyto-
chalasin D, suppressed their spreading on IgE-coated sur-
faces (Fig. 7, B and C), suggesting that actin polymerization
is critical in this process. WIP/ BMMCs had reduced abil-
ity to spread and form protrusions (Fig. 7 C).
Figure 5. Activation of MAP kinases in response to FcRI ligation.
BMMCs were stimulated for the indicated times and lysed in SDS-PAGE
sample buffer. Aliquots of the lysates were analyzed in parallel for phos-
phorylation of ERK1/2 (A), p38 (B), and SAPK/JNK (C) by Western
blotting with the corresponding phospho-specific antibodies. Membranes
were reprobed with kinase-specific antibodies to control for loading.
Representative blots of three experiments are shown. Mean fold induction
(n  3) normalized to signal for loading was determined by densitometry.
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Electron microscopy revealed that WIP/ BMMCs that
spread on IgE-coated coverslips had no obvious abnormali-
ties in their subcortical actin network (Fig. 7 D). These re-
sults suggest that FcRI-mediated actin polymerization–
dependent spreading and protrusion formation is impaired
in WIP/ mast cells.
FcRI Induction of Changes in F-Actin Content Is Abnormal
in WIP BMMCs. FcRI signaling induces changes in
cellular F-actin content in mast cells lines (21, 43). We
compared F-actin content in WT and WIP/ BMMCs af-
ter FcRI ligation. Resting WIP/ BMMCs had a re-
duced baseline F-actin content compared with WT
BMMCs. The mean reduction of cellular F-actin in WIP/
BMMCs was 12  2.4% in five experiments (P  0.01).
FcRI ligation in WT BMMCs resulted in an initial de-
crease in F-actin content, with the maximum decrease be-
ing observed after 2 min of stimulation. Subsequently,
F-actin content slowly increased but was still lower than base-
line 30 min after FcRI ligation (Fig. 8 A). The rapid de-
crease of F-actin was found to be dependent on the influx
of extracellular calcium as no change of F-actin content
was observed in the presence of EGTA and as ionomycin
also caused a decrease in F-actin content that was sustained
(not depicted). WIP/ BMMCs exhibited an initial de-
crease in F-actin that was similar to that observed in WT
controls. However, in contrast to what was observed in
WT BMMCs, the F-actin content of WIP/ BMMCs re-
turned almost immediately back to prestimulation level
(Fig. 8 A).
To further examine F-actin dynamics, we determined the
number of free pointed and barbed ends of F-actin filaments
in WT and WIP/ BMMCs after FcRI ligation. The
number of pointed ends in both types of BMMCs exceeded
by 30–40-fold that of barbed ends, suggesting that as ex-
pected, the vast majority of barbed ends are capped (Fig. 8
B). FcRI ligation in WT BMMCs caused rapid generation
of both pointed and barbed ends that peaked at 1–2 min,
with a progressive decrease in the next 15 min. Unstimu-
lated WIP/ BMMCs had significantly less pointed ends
than WT BMMCs, consistent with their lower baseline
content of F-actin. FcRI ligation in WIP/ BMMCs
caused an increase in the number of pointed ends that was
of a similar relative magnitude to that observed in WT
BMMCs (Fig. 8 B). This result, together with the compara-
ble decrease in total F-actin content in WIP/ and WT
BMMCs, suggests that actin depolymerization and/or sev-
Figure 6. WIP associates with Syk after FcRI ligation and protects it from degradation. (A) Association of WIP and Syk after FcRI ligation. WIP
immunoprecipitates from WT BMMCs were probed with Syk before and after FcRI ligation. (B) Syk protein levels in Western blots from lysates of
WT and WIP/ BMMCs. (C) Syk phosphorylation after FcRI ligation in WT and WIP/ BMMCs. Syk immunoprecipitates were probed with
antiphosphotyrosine mAb 4G10 and with anti-Syk as loading control. Numbers represent densitometric ratio of phopshoSyk to Syk bands. (D) Northern
blot analysis of Syk mRNA in WT and WIP/ BMMCs. 28S RNA is shown as loading control. (E) Effect of pretreatment with calpeptin and MG132
for 6 h on Syk levels in WT and WIP/ BMMCs.
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ering is not impaired in the absence of WIP. In contrast to
WT BMMCs, WIP/ BMMCs exhibited only a small in-
crease in the number of barbed ends (Fig. 7 B). This result,
together with the accelerated return of total F-actin content
to normal in WIP/ BMMCs, suggests that generation
and/or elongation and capping of actin filaments proceeds
more efficiently in the absence of WIP.
FcRI Induction of Cell Shape Changes Is Dysregulated in
WIP BMMCs. FcRI signaling evokes changes in cell
shape in mast cells (43, 44). Mast cells in the tissue are in
contact with proteins of the extracellular matrix. In an at-
tempt to simulate this environment we developed an assay
where we allowed the cells to spread on fibronectin-coated
glass coverslips and monitored the cell shape dynamics after
FcRI stimulation with video microscopy. BMMCs prein-
cubated with IgE were allowed to spread at 37	C on fi-
bronectin-coated glass coverslips and after an initial obser-
vation time of 1 min, the cross-linking antibody was added
and cells were monitored for 12 min thereafter (Fig. 8 C).
As shown in Fig. 8 C at time 0, both cell types spread and
extended membrane protrusions on the fibronectin-coated
surface. 2 min after FcRI cross-linking, both WT and
WIP/ cells had retracted their membrane protrusions and
rounded up. This retractile phase lasted 8 min in WT
BMMCs, after which the cells started to resume their orig-
inal spread shape and to extend membrane protrusions. In
contrast, the retractile phase was very transient in WIP/
BMMCs, lasting only 2 min. These results suggest that
WIP regulates the kinetics of recovery of cell shape after
the retraction induced by FcRI ligation.
Discussion
Here we report that mast cells that lack WIP are im-
paired in their response to FcRI ligation and provide evi-
dence that WIP controls Syk levels and FcRI signaling in
mast cells and regulates actin cytoskeleton rearrangement
triggered by FcRI ligation.
WIP is not essential for mast cell growth and differentia-
tion in vivo and in vitro as equal numbers of tissue mast
cells were detected in ears of WIP/ mice and the differ-
entiation and development of BMMCs of WIP/ mice in
vitro were normal. Mast cell development is mainly driven
by IL-3 (23) and other cytokines such as stem cell factor
Figure 7. Adhesion and spreading of BMMCs on
IgE-coated glass slides. (A) Quantification of BMMCs
that adhered to IgE-coated glass coverslips. Cells were
incubated for 1 h on IgE-coated glass coverslips. The
percentage of adherent cells was then determined by
-hexosaminidase content of attached versus detached
cells. (B) Quantification of BMMCs spread on IgE-
coated glass coverslips. Cells were fixed at indicated
time points and were counted under the microscope
(400) to determine the ratio of round versus spread
cells. BMMCs preincubated with cytochalasin D were
counted after 1 h of incubation. Results represent ratio
of spread/round cells of 500 cells per condition
counted from two independent experiments. (C) Rep-
resentative frames of WT (left), WT treated with cyto-
chalasin D (middle), and WIP/ (right) BMMCs
incubated on IgE-coated glass slides (400). (D) Cells
that adhered to IgE-coated glass coverslips after 1 h of
incubation were extracted and cytoskeletons were
metal coated. Bars, 1 mm.
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(45), but is thought not to be dependent on signals from
FcRI as it proceeds normally in FcRI/ mice (31).
WIP-deficient mice were resistant to IgE-mediated sys-
temic histamine release, an event which has been shown to
be dependent both on mast cells and FcRI signaling (28–
31). Because the plasma histamine levels in these mice after
intravenous antigen challenge remained low as compared
with WT controls, we conclude that WIP is a critical com-
ponent of the FcRI signaling pathway.
BMMCs isolated from WIP-deficient mice released sig-
nificantly less -hexosaminidase and produced lower
amounts of IL-6 after FcRI ligation than BMMCs derived
from WT littermates. Considered, respectively, as early and
late events triggered by ligation of the FcRI, degranula-
tion and IL-6 production both depend on increased and
sustained intracellular calcium levels. Upon FcRI cross-
linking, intracellular calcium levels were lower and less sus-
tained in WIP/ BMMCs as compared with WT cells.
The rise of intracellular calcium concentration is dependent
on the activation of PLC-. In accordance, PLC-2 tyro-
sine phosphorylation was reduced in WIP/ cells.
Propagation of the FcRI signal is dependent on Syk.
WIP was found to associate with Syk after FcRI ligation.
This is consistent with our previous finding that WIP asso-
ciates with ZAP-70 after TCR ligation (24). It is likely that
the association of WIP with Syk is mediated by the adaptor
protein CrkL. CrkL directly and constitutively binds to
WIP via SH3 domain–proline-rich region interactions and
is recruited to phosphorylated Syk via SH2 domain–phos-
photyrosine interactions (24, 37). This may result in the
formation of an Syk–CrkL–WIP complex after FcRI liga-
tion. Our data strongly suggests that WIP inhibits the deg-
radation of Syk. Syk protein levels, but not Syk mRNA
levels, were selectively diminished in WIP/ BMMCs.
Diminished Syk levels and the subsequent decrease in
phospho-Syk levels after FcRI ligation in WIP/ BMMCs
probably contributes to impaired FcRI signaling in these
cells. The observation that phosphorylation of PLC-2, but
not of SLP-76, was diminished in WIP/ BMMCs suggests
that tyrosine kinases other than Syk may participate in SLP-
76 phosphorylation after FcRI ligation.
After FcRI ligation, Cbl is recruited to Syk and phos-
phorylated. This causes it to ubiquinate Syk, targeting it for
degradation by the proteasome (38, 40). Phosphorylated
Cbl can recruit CrkL via interaction with its SH2 domain
(46, 47). This may result in the formation of an Syk–Cbl–
CrkL–WIP complex. Furthermore, Syk is a target for deg-
radation by calpain (48). This may occur in lipid rafts
Figure 8. Determination of cellular F-actin and time lapse video microscopy of BMMCs activated by FcRI ligation. (A) IgE-sensitized BMMCs were
stimulated by cross-linking of FcRI for the indicated time. Cells were then fixed, permeabilized, stained with phalloidin-TRITC, and analyzed by
FACS®. Results represent mean  SD of three experiments. (B) Barbed and pointed end counts of activated BMMCs determined by pyrene-labeled actin
assembly assay. (C) IgE-sensitized BMMCs were allowed to attach to fibronectin-coated glass coverslips for 20 min at 37	C. Cells were then videotaped for
15 min and FcRI cross-linking was induced after 1 min (frame 0). The indicated time frames were processed using NIH Image software. 400.  on
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where activated Syk is recruited and where calpain is
present constitutively (not depicted). The diminished level
of Syk in WIP-deficient mast cells and its partial rescue by
calpain and proteasome inhibitors suggest that WIP may
interfere with Cbl ubiquitination of Syk and with its degra-
dation by calpain. The requirement for both calpain and
proteasome inhibitors for this rescue suggests that calpain
and the ubiquitin/proteasome pathway synergize in de-
grading Syk in WIP/ mast cells.
IL-6 production after FcRI cross-linking has been
shown to be strongly linked to JNK activation in mast cells
(49, 50). The impaired capacity of WIP/ to produce IL-6
in response to FcRI ligation was paralleled by reduced
phosphorylation of JNK kinase observed in these cells.
WIP could potentially modulate JNK activation via its ef-
fect on actin polymerization, as JNK has been shown to be
regulated by the actin cytoskeleton (51). Alternatively,
WIP, through its interaction with WASP, might induce
transcriptional activation independent of actin polymeriza-
tion as it has been proposed in T cells (12).
WIP-deficient BMMCs adhered to IgE-coated cover-
slips and undergo similar morphological changes as WT
cells, although the number of cells that spread after 1 h of
incubation was significantly decreased. IgE-induced spread-
ing was dependent on actin polymerization as it was inhib-
ited by cytochalasin D. Electron microscopy revealed that
WIP/ cells that spread had the same pattern of cortical
actin network as WT cells, indicating that actin polymer-
ization involved in the formation of motile protrusions in
mast cells is unaffected by lack of WIP/. This finding was
surprising because T and B cells from WIP-deficient mice
display abnormal cortical actin networks when they are in-
cubated on anti-TCR– or anti–B cell receptor–coated cov-
erslips (13). These results suggest that actin polymerization
is differently regulated in mast cells after FcRI ligation
compared with TCR engagement in T cells and surface
IgM cross-linking in B cells. TCR and B cell receptor liga-
tion triggers actin polymerization in T and B cells reflected
by an increase of F-actin content (52). In contrast, F-actin
content rapidly decreased in mast cells after FcRI ligation.
This initial decrease in F-actin content was followed by a
subsequent gradual increase of F-actin to almost prestimu-
lation levels. Using time lapse video microscopy, we were
able to follow the morphological changes triggered by
FcRI ligation in BMMCs that were allowed to spread on
fibronectin-coated glass coverslips. Upon stimulation, these
changes consisted of an initial rounding of the cells fol-
lowed by a slow resumption of the spread state in WT
BMMCs. The kinetics of these changes paralleled those
observed in the F-actin content, suggesting that BMMCs
rapidly depolymerize F-actin after FcRI ligation followed
by a phase of actin polymerization. Furthermore, these re-
sults are in accordance with the findings that the increase in
the number of pointed ends after FcRI ligation were
comparable in WIP/ and WT BMMCs, suggesting that
actin depolymerization and/or severing is not impaired in
the absence of WIP. Experiments with permeabilized mast
cells have suggested that in the early phase of the degranu-
lation process actin is depolymerized or severed (53–55).
Furthermore, mast cell degranulation is enhanced in the
presence of cytochalasin D and latrunculin, inhibitors that
disrupt actin microfilaments without causing degranulation
per se (21, 22). The disassembly of cortical actin has been
shown to be dependent on calcium and involved the actin
filament severing and capping protein gelsolin and Rho
GTPases (53–56). The small Rho family GTPases Rac and
Cdc42 have been shown to regulate mast cell function.
GTP-Cdc42 binds to WASP and activates its ability to in-
teract with the Arp2/3 complex and to induce actin poly-
merization (57–59). WIP retards N-WASP/Cdc42–acti-
vated actin polymerization (60). Furthermore, we have
recently shown that TCR ligation results in protein kinase
C –mediated phosphorylation of WIP and its subsequent
dissociation from WASP might be required for F-actin ac-
cumulation in T cells (24). This dissociation releases WASP
from the inhibitory effect of WIP, allowing it to get acti-
vated by Cdc42. Thus, in the absence of WIP, WASP-
mediated actin polymerization might progress more rap-
idly. This regulatory role for WIP may explain our results
that WIP-deficient BMMCs increase their F-actin content
more rapidly after FcRI ligation and remain in the re-
tracted state for a shorter time than WT BMMCs. Alterna-
tively, WIP may regulate actin polymerization directly.
The observation that WIP/ BMMCs exhibited only a
small increase in the number of barbed ends after FcRI li-
gation suggests that barbed ends are more efficiently capped
and/or that filaments are more efficiently elongated in the
absence of WIP. This would then result in accelerated re-
turn of total F-actin content to normal.
In summary, our findings suggest that WIP regulates IgE-
dependent mast cell activation by regulating Syk levels,
FcRI signaling, and actin cytoskeletal reorganization, and
may represent potential therapeutic targets in allergic diseases.
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